Concord Biotech Ltd.
•₹ 1,571.3-0.34%
2026-08-21
PROS
- Company is almost debt free
- Company has a healthy return on capital (ROCE) of 25.6%
- Company has consistently been profitable over the last 5 years
- Latest quarter profit grew 31.0% YoY, showing strong momentum
- Company has been maintaining a healthy dividend payout of 30.3%
CONS
- Recent results are weak - TTM profit is down 26.0% versus prior year
- Company has delivered a poor profit growth of 2.0% over past five years
- Operating margins have contracted to 34.9% from 45.0%
- Stock is trading at 5.3x its book value
- Expensive relative to growth - PEG of 23.2
- Inventory has been piling up - inventory days up from 68 to 98
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | CONCORDBIO | 1585.10 | 60.22 | 16582.71 | 0.48 | 57.70 | 30.96 | 257.49 | 26.23 | 18.04 | 32.49 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 195 | 262 | 241 | 319 | 216 | 310 | 244 | 430 | 204 | 247 | 278 | 326 | 257 | |
| 123 | 143 | 135 | 185 | 135 | 174 | 146 | 239 | 143 | 159 | 179 | 208 | 193 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 7 | 8 | 8 | 11 | 10 | 10 | 15 | 9 | 14 | 13 | 10 | 15 | 13 |
| Interest | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 13 | 13 | 14 | 14 | 13 | 13 | 13 | 15 | 18 | 18 | 19 | 20 | 18 |
| 65 | 113 | 100 | 131 | 78 | 133 | 99 | 185 | 57 | 83 | 87 | 114 | 78 | |
| Tax % | 25.44% | 25.35% | 25.51% | 25.74% | 25.50% | 25.95% | 25.40% | 23.32% | 25.63% | 27.13% | 25.92% | 22.42% | 26.35% |
| Net Profit | 0 | 0 | 0 | 0 | 60 | 96 | 76 | 140 | 44 | 63 | 64 | 88 | 58 |
| 5 | 8 | 7 | 9 | 6 | 9 | 7 | 13 | 4 | 6 | 6 | 8 | 1 | |
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 195
- 123
- Operating Profit
- —
- OPM %
- —
- Other Income
- 7
- Interest
- 1
- Depreciation
- 13
- 65
- Tax %
- 25.44%
- Net Profit
- 0
- 5
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 262
- 143
- Operating Profit
- —
- OPM %
- —
- Other Income
- 8
- Interest
- 1
- Depreciation
- 13
- 113
- Tax %
- 25.35%
- Net Profit
- 0
- 8
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 241
- 135
- Operating Profit
- —
- OPM %
- —
- Other Income
- 8
- Interest
- 0
- Depreciation
- 14
- 100
- Tax %
- 25.51%
- Net Profit
- 0
- 7
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 319
- 185
- Operating Profit
- —
- OPM %
- —
- Other Income
- 11
- Interest
- 0
- Depreciation
- 14
- 131
- Tax %
- 25.74%
- Net Profit
- 0
- 9
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 216
- 135
- Operating Profit
- —
- OPM %
- —
- Other Income
- 10
- Interest
- 0
- Depreciation
- 13
- 78
- Tax %
- 25.50%
- Net Profit
- 60
- 6
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 310
- 174
- Operating Profit
- —
- OPM %
- —
- Other Income
- 10
- Interest
- 0
- Depreciation
- 13
- 133
- Tax %
- 25.95%
- Net Profit
- 96
- 9
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 244
- 146
- Operating Profit
- —
- OPM %
- —
- Other Income
- 15
- Interest
- 0
- Depreciation
- 13
- 99
- Tax %
- 25.40%
- Net Profit
- 76
- 7
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 430
- 239
- Operating Profit
- —
- OPM %
- —
- Other Income
- 9
- Interest
- 0
- Depreciation
- 15
- 185
- Tax %
- 23.32%
- Net Profit
- 140
- 13
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 204
- 143
- Operating Profit
- —
- OPM %
- —
- Other Income
- 14
- Interest
- 0
- Depreciation
- 18
- 57
- Tax %
- 25.63%
- Net Profit
- 44
- 4
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 247
- 159
- Operating Profit
- —
- OPM %
- —
- Other Income
- 13
- Interest
- 0
- Depreciation
- 18
- 83
- Tax %
- 27.13%
- Net Profit
- 63
- 6
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 278
- 179
- Operating Profit
- —
- OPM %
- —
- Other Income
- 10
- Interest
- 0
- Depreciation
- 19
- 87
- Tax %
- 25.92%
- Net Profit
- 64
- 6
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 326
- 208
- Operating Profit
- —
- OPM %
- —
- Other Income
- 15
- Interest
- 0
- Depreciation
- 20
- 114
- Tax %
- 22.42%
- Net Profit
- 88
- 8
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 257
- 193
- Operating Profit
- —
- OPM %
- —
- Other Income
- 13
- Interest
- 0
- Depreciation
- 18
- 78
- Tax %
- 26.35%
- Net Profit
- 58
- 1
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 10
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| 512 | 617 | 713 | 853 | 1,017 | 1,200 | 1,055 | 1,108 | |
| 308 | 289 | 439 | 505 | 585 | 693 | 687 | 738 | |
| Operating Profit | 236 | 342 | 297 | 384 | 466 | 551 | 420 | — |
| OPM % | 46 | 55 | 42 | 45 | 46 | 46 | 40 | — |
| Other Income | 31 | 14 | 23 | 35 | 34 | 44 | 52 | 52 |
| Interest | 1 | 1 | 6 | 10 | 3 | 1 | 1 | 0 |
| Depreciation | 21 | 28 | 50 | 54 | 54 | 54 | 74 | 75 |
| 213 | 313 | 238 | 322 | 413 | 495 | 345 | 363 | |
| Tax % | 21 | 25 | 26 | 25 | 25 | 25 | 25 | 25 |
| Net Profit | 169 | 235 | 175 | 240 | 308 | 372 | 259 | 271 |
| EPS | 178 | 22 | 17 | 23 | 29 | 36 | 25 | — |
| Dividend Payout % | 3 | 30 | 28 | 30 | 30 | 30 | 30 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 2 | -1 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| Adjusted EPS | 16 | 22 | 17 | 23 | 29 | 36 | 25 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 2 | -1 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| Adjusted EPS | 16 | 22 | 17 | 23 | 29 | 36 | 25 | — |
Mar 2020
- 512
- 308
- Operating Profit
- 236
- OPM %
- 46
- Other Income
- 31
- Interest
- 1
- Depreciation
- 21
- 213
- Tax %
- 21
- Net Profit
- 169
- EPS
- 178
- Dividend Payout %
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 16
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 16
Mar 2021
- 617
- 289
- Operating Profit
- 342
- OPM %
- 55
- Other Income
- 14
- Interest
- 1
- Depreciation
- 28
- 313
- Tax %
- 25
- Net Profit
- 235
- EPS
- 22
- Dividend Payout %
- 30
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 22
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 22
Mar 2022
- 713
- 439
- Operating Profit
- 297
- OPM %
- 42
- Other Income
- 23
- Interest
- 6
- Depreciation
- 50
- 238
- Tax %
- 26
- Net Profit
- 175
- EPS
- 17
- Dividend Payout %
- 28
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 17
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 17
Mar 2023
- 853
- 505
- Operating Profit
- 384
- OPM %
- 45
- Other Income
- 35
- Interest
- 10
- Depreciation
- 54
- 322
- Tax %
- 25
- Net Profit
- 240
- EPS
- 23
- Dividend Payout %
- 30
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 23
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 23
Mar 2024
- 1,017
- 585
- Operating Profit
- 466
- OPM %
- 46
- Other Income
- 34
- Interest
- 3
- Depreciation
- 54
- 413
- Tax %
- 25
- Net Profit
- 308
- EPS
- 29
- Dividend Payout %
- 30
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 29
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 29
Mar 2025
- 1,200
- 693
- Operating Profit
- 551
- OPM %
- 46
- Other Income
- 44
- Interest
- 1
- Depreciation
- 54
- 495
- Tax %
- 25
- Net Profit
- 372
- EPS
- 36
- Dividend Payout %
- 30
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 36
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 36
Mar 2026
- 1,055
- 687
- Operating Profit
- 420
- OPM %
- 40
- Other Income
- 52
- Interest
- 1
- Depreciation
- 74
- 345
- Tax %
- 25
- Net Profit
- 259
- EPS
- 25
- Dividend Payout %
- 30
- Minority Interest
- 2
- Share of Associates
- 0
- Adjusted EPS
- 25
- Minority Interest
- 2
- Share of Associates
- 0
- Adjusted EPS
- 25
TTM
- 1,108
- 738
- Operating Profit
- —
- OPM %
- —
- Other Income
- 52
- Interest
- 0
- Depreciation
- 75
- 363
- Tax %
- 25
- Net Profit
- 271
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- -1
- Share of Associates
- 3
- Adjusted EPS
- —
- Minority Interest
- -1
- Share of Associates
- 3
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- 11%
- 3 Years:
- 7%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- 2%
- 3 Years:
- 3%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- 18%
- 1 Year:
- -7%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- 19%
- 3 Years:
- 19%
- Last Year:
- 14%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - |
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| 761 | 990 | 1,094 | 1,280 | 1,516 | 1,802 | 2,007 | |
| 12 | 30 | 29 | 25 | 0 | 0 | 0 | |
| Trade Payables | 71 | 46 | 83 | 94 | 94 | 113 | 102 |
| 195 | 237 | 286 | 105 | 80 | 108 | 113 | |
| Total Liabilities | 1,049 | 1,313 | 1,502 | 1,514 | 1,701 | 2,034 | 2,232 |
| ASSETS | - | - | - | - | - | - | - |
| 240 | 546 | 573 | 593 | 575 | 795 | 789 | |
| Capital Work in Progress | 141 | 18 | 74 | 173 | 211 | 50 | 78 |
| 199 | 141 | 74 | 137 | 246 | 335 | 491 | |
| 111 | 154 | 195 | 212 | 208 | 240 | 326 | |
| 0 | 0 | 0 | 0 | 350 | 522 | 460 | |
| Cash & Bank | 3 | 61 | 89 | 43 | 47 | 1 | 14 |
| 355 | 393 | 497 | 355 | 64 | 92 | 74 | |
| Total Assets | 1,049 | 1,313 | 1,502 | 1,514 | 1,701 | 2,034 | 2,232 |
| Total Debt | 48 | 86 | 61 | 31 | 6 | 0 | 0 |
| Net Working Capital | 315 | 371 | 288 | 536 | 754 | 951 | 1,081 |
| Contingent Liabilities | 4 | 4 | 13 | 14 | 14 | 4 | 4 |
| Book Value per Share | 809.87 | 1050.75 | 1159.94 | 123.31 | 145.93 | 173.27 | 192.81 |
| Face Value | 10.00 | 10.00 | 10.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Total Debt | 48 | 86 | 61 | 31 | 6 | 0 | 0 |
| Net Working Capital | 315 | 371 | 288 | 536 | 754 | 951 | 1,081 |
| Contingent Liabilities | 4 | 4 | 13 | 14 | 14 | 4 | 4 |
| Book Value per Share | 809.87 | 1050.75 | 1159.94 | 123.31 | 145.93 | 173.27 | 192.81 |
| Face Value | 10.00 | 10.00 | 10.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Mar 2020
- Equity Capital
- 10
- 761
- 12
- Trade Payables
- 71
- 195
- Total Liabilities
- 1,049
- 240
- Capital Work in Progress
- 141
- 199
- 111
- 0
- Cash & Bank
- 3
- 355
- Total Assets
- 1,049
- Total Debt
- 48
- Net Working Capital
- 315
- Contingent Liabilities
- 4
- Book Value per Share
- 809.87
- Face Value
- 10.00
- Total Debt
- 48
- Net Working Capital
- 315
- Contingent Liabilities
- 4
- Book Value per Share
- 809.87
- Face Value
- 10.00
Mar 2021
- Equity Capital
- 10
- 990
- 30
- Trade Payables
- 46
- 237
- Total Liabilities
- 1,313
- 546
- Capital Work in Progress
- 18
- 141
- 154
- 0
- Cash & Bank
- 61
- 393
- Total Assets
- 1,313
- Total Debt
- 86
- Net Working Capital
- 371
- Contingent Liabilities
- 4
- Book Value per Share
- 1050.75
- Face Value
- 10.00
- Total Debt
- 86
- Net Working Capital
- 371
- Contingent Liabilities
- 4
- Book Value per Share
- 1050.75
- Face Value
- 10.00
Mar 2022
- Equity Capital
- 10
- 1,094
- 29
- Trade Payables
- 83
- 286
- Total Liabilities
- 1,502
- 573
- Capital Work in Progress
- 74
- 74
- 195
- 0
- Cash & Bank
- 89
- 497
- Total Assets
- 1,502
- Total Debt
- 61
- Net Working Capital
- 288
- Contingent Liabilities
- 13
- Book Value per Share
- 1159.94
- Face Value
- 10.00
- Total Debt
- 61
- Net Working Capital
- 288
- Contingent Liabilities
- 13
- Book Value per Share
- 1159.94
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 10
- 1,280
- 25
- Trade Payables
- 94
- 105
- Total Liabilities
- 1,514
- 593
- Capital Work in Progress
- 173
- 137
- 212
- 0
- Cash & Bank
- 43
- 355
- Total Assets
- 1,514
- Total Debt
- 31
- Net Working Capital
- 536
- Contingent Liabilities
- 14
- Book Value per Share
- 123.31
- Face Value
- 1.00
- Total Debt
- 31
- Net Working Capital
- 536
- Contingent Liabilities
- 14
- Book Value per Share
- 123.31
- Face Value
- 1.00
Mar 2024
- Equity Capital
- 10
- 1,516
- 0
- Trade Payables
- 94
- 80
- Total Liabilities
- 1,701
- 575
- Capital Work in Progress
- 211
- 246
- 208
- 350
- Cash & Bank
- 47
- 64
- Total Assets
- 1,701
- Total Debt
- 6
- Net Working Capital
- 754
- Contingent Liabilities
- 14
- Book Value per Share
- 145.93
- Face Value
- 1.00
- Total Debt
- 6
- Net Working Capital
- 754
- Contingent Liabilities
- 14
- Book Value per Share
- 145.93
- Face Value
- 1.00
Mar 2025
- Equity Capital
- 10
- 1,802
- 0
- Trade Payables
- 113
- 108
- Total Liabilities
- 2,034
- 795
- Capital Work in Progress
- 50
- 335
- 240
- 522
- Cash & Bank
- 1
- 92
- Total Assets
- 2,034
- Total Debt
- 0
- Net Working Capital
- 951
- Contingent Liabilities
- 4
- Book Value per Share
- 173.27
- Face Value
- 1.00
- Total Debt
- 0
- Net Working Capital
- 951
- Contingent Liabilities
- 4
- Book Value per Share
- 173.27
- Face Value
- 1.00
Mar 2026
- Equity Capital
- 10
- 2,007
- 0
- Trade Payables
- 102
- 113
- Total Liabilities
- 2,232
- 789
- Capital Work in Progress
- 78
- 491
- 326
- 460
- Cash & Bank
- 14
- 74
- Total Assets
- 2,232
- Total Debt
- 0
- Net Working Capital
- 1,081
- Contingent Liabilities
- 4
- Book Value per Share
- 192.81
- Face Value
- 1.00
- Total Debt
- 0
- Net Working Capital
- 1,081
- Contingent Liabilities
- 4
- Book Value per Share
- 192.81
- Face Value
- 1.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 155 | 167 | 207 | 246 | 265 | 245 | 267 | |
| Cash from Investing | -113 | -195 | -112 | -158 | -155 | -160 | -143 |
| Cash from Financing | -43 | 31 | -100 | -85 | -99 | -99 | -113 |
| -1 | 3 | -4 | 3 | 12 | -14 | 11 | |
| Free Cash Flow | 155 | -44 | 77 | 75 | 191 | 137 | 173 |
| OCF / Net Profit | 0.92 | 0.71 | 1.19 | 1.02 | 0.86 | 0.66 | 1.03 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | 436 | 653 |
| OCF / Net Profit | 0.92 | 0.71 | 1.19 | 1.02 | 0.86 | 0.66 | 1.03 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | 436 | 653 |
Mar 2020
- 155
- Cash from Investing
- -113
- Cash from Financing
- -43
- -1
- Free Cash Flow
- 155
- OCF / Net Profit
- 0.92
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.92
- Cumulative 5-Year FCF
- 0
Mar 2021
- 167
- Cash from Investing
- -195
- Cash from Financing
- 31
- 3
- Free Cash Flow
- -44
- OCF / Net Profit
- 0.71
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.71
- Cumulative 5-Year FCF
- 0
Mar 2022
- 207
- Cash from Investing
- -112
- Cash from Financing
- -100
- -4
- Free Cash Flow
- 77
- OCF / Net Profit
- 1.19
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.19
- Cumulative 5-Year FCF
- 0
Mar 2023
- 246
- Cash from Investing
- -158
- Cash from Financing
- -85
- 3
- Free Cash Flow
- 75
- OCF / Net Profit
- 1.02
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.02
- Cumulative 5-Year FCF
- 0
Mar 2024
- 265
- Cash from Investing
- -155
- Cash from Financing
- -99
- 12
- Free Cash Flow
- 191
- OCF / Net Profit
- 0.86
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.86
- Cumulative 5-Year FCF
- 0
Mar 2025
- 245
- Cash from Investing
- -160
- Cash from Financing
- -99
- -14
- Free Cash Flow
- 137
- OCF / Net Profit
- 0.66
- Cumulative 5-Year FCF
- 436
- OCF / Net Profit
- 0.66
- Cumulative 5-Year FCF
- 436
Mar 2026
- 267
- Cash from Investing
- -143
- Cash from Financing
- -113
- 11
- Free Cash Flow
- 173
- OCF / Net Profit
- 1.03
- Cumulative 5-Year FCF
- 653
- OCF / Net Profit
- 1.03
- Cumulative 5-Year FCF
- 653
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - |
| EPS (₹) | 177.66 | 246.92 | 183.92 | 22.95 | 29.45 | 35.52 | 24.94 |
| Book Value (₹) | 809.87 | 1050.75 | 1159.94 | 123.31 | 145.93 | 173.27 | 192.81 |
| Dividend per Share (₹) | 6.00 | 74.15 | 51.20 | 6.83 | 8.75 | 10.70 | 7.55 |
| Cash EPS (₹) | 18.18 | 25.08 | 21.50 | 28.11 | 34.57 | 40.72 | 31.90 |
| PROFITABILITY | - | - | - | - | - | - | - |
| Operating Margin % | 45.14% | 54.34% | 40.96% | 45.00% | 42.50% | 42.23% | 34.88% |
| Net Margin % | 32.33% | 37.35% | 24.10% | 28.14% | 30.30% | 30.97% | 24.57% |
| ROE % | 21.94% | 26.55% | 16.64% | 20.06% | 21.88% | 22.26% | 13.54% |
| ROCE % | 26.23% | 32.96% | 21.66% | 26.70% | 29.13% | 29.62% | 18.04% |
| 16.11% | 19.89% | 12.43% | 15.92% | 19.17% | 19.90% | 12.15% | |
| EFFICIENCY | - | - | - | - | - | - | - |
| Debtor Days | 128 | 105 | 103 | 108 | 112 | 132 | 170 |
| Inventory Days | 78 | 77 | 88 | 87 | 75 | 68 | 98 |
| Payable Days | 200 | 192 | 144 | 179 | 150 | 124 | 160 |
| 6 | -11 | 47 | 16 | 37 | 77 | 108 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.06x | 0.09x | 0.05x | 0.02x | 0.00x | 0.00x | 0.00x |
| Interest Coverage (x) | 183.92x | 299.68x | 39.72x | 33.85x | 130.57x | 475.76x | 419.57x |
| 2.41x | 2.57x | 1.84x | 3.79x | 6.30x | 6.17x | 7.39x | |
| GROWTH | - | - | - | - | - | - | - |
| Revenue Growth % | 0.00% | 20.42% | 15.56% | 19.67% | 19.20% | 18.01% | -12.10% |
| Operating Profit Growth % | 0.00% | 44.86% | -12.99% | 29.11% | 21.38% | 18.31% | -23.76% |
| Net Profit Growth % | 0.00% | 39.02% | -25.53% | 37.25% | 28.33% | 20.62% | -30.25% |
| 0.00% | 0.00% | 0.00% | 0.00% | 28.33% | 20.62% | -29.80% | |
| VALUATION | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 51.68x | 47.19x | 40.73x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 10.43x | 9.67x | 5.27x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.57% | 0.64% | 0.74% |
| 0.00x | 0.00x | 0.00x | 0.00x | 34.08x | 31.81x | 25.25x |
Mar 2020
- EPS (₹)
- 177.66
- Book Value (₹)
- 809.87
- Dividend per Share (₹)
- 6.00
- Cash EPS (₹)
- 18.18
- Operating Margin %
- 45.14%
- Net Margin %
- 32.33%
- ROE %
- 21.94%
- ROCE %
- 26.23%
- 16.11%
- Debtor Days
- 128
- Inventory Days
- 78
- Payable Days
- 200
- 6
- Debt to Equity (x)
- 0.06x
- Interest Coverage (x)
- 183.92x
- 2.41x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 246.92
- Book Value (₹)
- 1050.75
- Dividend per Share (₹)
- 74.15
- Cash EPS (₹)
- 25.08
- Operating Margin %
- 54.34%
- Net Margin %
- 37.35%
- ROE %
- 26.55%
- ROCE %
- 32.96%
- 19.89%
- Debtor Days
- 105
- Inventory Days
- 77
- Payable Days
- 192
- -11
- Debt to Equity (x)
- 0.09x
- Interest Coverage (x)
- 299.68x
- 2.57x
- Revenue Growth %
- 20.42%
- Operating Profit Growth %
- 44.86%
- Net Profit Growth %
- 39.02%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 183.92
- Book Value (₹)
- 1159.94
- Dividend per Share (₹)
- 51.20
- Cash EPS (₹)
- 21.50
- Operating Margin %
- 40.96%
- Net Margin %
- 24.10%
- ROE %
- 16.64%
- ROCE %
- 21.66%
- 12.43%
- Debtor Days
- 103
- Inventory Days
- 88
- Payable Days
- 144
- 47
- Debt to Equity (x)
- 0.05x
- Interest Coverage (x)
- 39.72x
- 1.84x
- Revenue Growth %
- 15.56%
- Operating Profit Growth %
- -12.99%
- Net Profit Growth %
- -25.53%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 22.95
- Book Value (₹)
- 123.31
- Dividend per Share (₹)
- 6.83
- Cash EPS (₹)
- 28.11
- Operating Margin %
- 45.00%
- Net Margin %
- 28.14%
- ROE %
- 20.06%
- ROCE %
- 26.70%
- 15.92%
- Debtor Days
- 108
- Inventory Days
- 87
- Payable Days
- 179
- 16
- Debt to Equity (x)
- 0.02x
- Interest Coverage (x)
- 33.85x
- 3.79x
- Revenue Growth %
- 19.67%
- Operating Profit Growth %
- 29.11%
- Net Profit Growth %
- 37.25%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 29.45
- Book Value (₹)
- 145.93
- Dividend per Share (₹)
- 8.75
- Cash EPS (₹)
- 34.57
- Operating Margin %
- 42.50%
- Net Margin %
- 30.30%
- ROE %
- 21.88%
- ROCE %
- 29.13%
- 19.17%
- Debtor Days
- 112
- Inventory Days
- 75
- Payable Days
- 150
- 37
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 130.57x
- 6.30x
- Revenue Growth %
- 19.20%
- Operating Profit Growth %
- 21.38%
- Net Profit Growth %
- 28.33%
- 28.33%
- P/E (x)
- 51.68x
- P/B (x)
- 10.43x
- Dividend Yield %
- 0.57%
- 34.08x
Mar 2025
- EPS (₹)
- 35.52
- Book Value (₹)
- 173.27
- Dividend per Share (₹)
- 10.70
- Cash EPS (₹)
- 40.72
- Operating Margin %
- 42.23%
- Net Margin %
- 30.97%
- ROE %
- 22.26%
- ROCE %
- 29.62%
- 19.90%
- Debtor Days
- 132
- Inventory Days
- 68
- Payable Days
- 124
- 77
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 475.76x
- 6.17x
- Revenue Growth %
- 18.01%
- Operating Profit Growth %
- 18.31%
- Net Profit Growth %
- 20.62%
- 20.62%
- P/E (x)
- 47.19x
- P/B (x)
- 9.67x
- Dividend Yield %
- 0.64%
- 31.81x
Mar 2026
- EPS (₹)
- 24.94
- Book Value (₹)
- 192.81
- Dividend per Share (₹)
- 7.55
- Cash EPS (₹)
- 31.90
- Operating Margin %
- 34.88%
- Net Margin %
- 24.57%
- ROE %
- 13.54%
- ROCE %
- 18.04%
- 12.15%
- Debtor Days
- 170
- Inventory Days
- 98
- Payable Days
- 160
- 108
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 419.57x
- 7.39x
- Revenue Growth %
- -12.10%
- Operating Profit Growth %
- -23.76%
- Net Profit Growth %
- -30.25%
- -29.80%
- P/E (x)
- 40.73x
- P/B (x)
- 5.27x
- Dividend Yield %
- 0.74%
- 25.25x
Documents
Announcements
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-07 - Concord Biotech Limited has informed the Exchange about Transcript
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-03 - Concord Biotech Limited has informed the Exchange about Link of Recording
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Aug 2026
Jun 2026
May 2026